ProPhase Labs, Inc.: other nonoperating income or expense
Other nonoperating income or expense for ProPhase Labs, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ProPhase Labs, Inc. financial histories
What this measure means
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
Exact concept: us-gaap:OtherNonoperatingIncomeExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2015-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -174,000 | USD | 2026-06-01 | 10-K · 0000868278-26-000005 |
| 2024-01-01 | 2024-12-31 | -18,000 | USD | 2026-06-01 | 10-K · 0000868278-26-000005 |
| 2023-01-01 | 2023-12-31 | 10,000 | USD | 2025-04-01 | 10-K · 0000868278-25-000003 |
| 2022-01-01 | 2022-12-31 | 0 | USD | 2024-03-29 | 10-K · 0000868278-24-000004 |
| 2017-01-01 | 2017-12-31 | 54,000 | USD | 2018-08-20 | 10-K/A · 0001493152-18-012362 |
| 2016-01-01 | 2016-12-31 | 187,000 | USD | 2018-08-20 | 10-K/A · 0001493152-18-012362 |
| 2015-01-01 | 2015-12-31 | 11,000 | USD | 2018-08-20 | 10-K/A · 0001493152-18-012362 |
Related financial histories
- ProPhase Labs, Inc.: total assets
- ProPhase Labs, Inc.: total liabilities
- ProPhase Labs, Inc.: stockholders equity
- ProPhase Labs, Inc.: cash and cash equivalents
- ProPhase Labs, Inc.: net income or loss
- ProPhase Labs, Inc.: operating cash flow
- ProPhase Labs, Inc.: capital expenditure payments
- ProPhase Labs, Inc.: contract revenue excluding tax
- ProPhase Labs, Inc.: financing cash flow
- ProPhase Labs, Inc.: investing cash flow
- ProPhase Labs, Inc.: retained earnings or deficit
- ProPhase Labs, Inc.: basic weighted-average shares
- ProPhase Labs, Inc.: diluted weighted-average shares
- ProPhase Labs, Inc.: basic earnings per share
- ProPhase Labs, Inc.: diluted earnings per share
- ProPhase Labs, Inc.: income tax expense or benefit
- ProPhase Labs, Inc.: net property, plant and equipment
- ProPhase Labs, Inc.: share-based compensation expense
- ProPhase Labs, Inc.: operating income or loss
- ProPhase Labs, Inc.: current assets
- ProPhase Labs, Inc.: interest expense
- ProPhase Labs, Inc.: current liabilities
- ProPhase Labs, Inc.: current accounts payable
- ProPhase Labs, Inc.: goodwill carrying amount
- ProPhase Labs, Inc.: net finite-lived intangible assets
- ProPhase Labs, Inc.: net current accounts receivable
- ProPhase Labs, Inc.: common-stock repurchase payments
- ProPhase Labs, Inc.: operating expenses
- ProPhase Labs, Inc.: net inventory
- ProPhase Labs, Inc.: gross profit
- ProPhase Labs, Inc.: research and development expense
- ProPhase Labs, Inc.: common shares outstanding
- ProPhase Labs, Inc.: cash including restricted cash
- ProPhase Labs, Inc.: additional paid-in capital
- ProPhase Labs, Inc.: accumulated other comprehensive income or loss
- ProPhase Labs, Inc.: operating lease right-of-use asset
- ProPhase Labs, Inc.: operating lease liability
- ProPhase Labs, Inc.: gross property, plant and equipment
- ProPhase Labs, Inc.: accumulated depreciation on property, plant and equipment
- ProPhase Labs, Inc.: net intangible assets excluding goodwill
- ProPhase Labs, Inc.: other noncurrent assets
- ProPhase Labs, Inc.: accrued current liabilities
- ProPhase Labs, Inc.: prepaid expenses and other current assets
- ProPhase Labs, Inc.: current contract liabilities
- ProPhase Labs, Inc.: net deferred tax liabilities
- ProPhase Labs, Inc.: pre-tax income or loss from continuing operations
- ProPhase Labs, Inc.: comprehensive income or loss
- ProPhase Labs, Inc.: net income available to common stockholders
- ProPhase Labs, Inc.: general and administrative expense
- ProPhase Labs, Inc.: depreciation expense
- ProPhase Labs, Inc.: depreciation, depletion and amortization
- ProPhase Labs, Inc.: amortization of intangible assets
- ProPhase Labs, Inc.: nonoperating interest expense
- ProPhase Labs, Inc.: current income tax expense or benefit
- ProPhase Labs, Inc.: deferred income tax expense or benefit
- ProPhase Labs, Inc.: interest paid, net
- ProPhase Labs, Inc.: income taxes paid, net
- ProPhase Labs, Inc.: proceeds from issuing common stock
- ProPhase Labs, Inc.: operating lease payments
- ProPhase Labs, Inc.: change in accounts receivable
- ProPhase Labs, Inc.: change in inventories
- ProPhase Labs, Inc.: change in accounts payable
Inspect the source
- Entity
- ProPhase Labs, Inc. / CIK 0000868278
- Captured
- 2026-09-20T05:00:19.207Z
- SEC response SHA-256
7de1fb04b8b96345db34059d99a10a3a895553427f4f28301756cddef324a67c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000868278.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))